Antimicrobial resistance

Worldwide Antibiotics Industry to 2026 - Featuring Pfizer, Bayer and Novartis Among Others

Retrieved on: 
Tuesday, March 30, 2021
Health sciences, Articles, Health, Beta-lactam antibiotics, Evolutionary biology, Pharmaceuticals policy, Veterinary medicine, Antimicrobial resistance, Antibiotic, Beta-lactamase, β-Lactamase inhibitor, Drug resistance

The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.

Key Points: 
  • The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.
  • Presently, the demand for beta-lactam and beta-lactamase inhibitors class of antibiotics is more among healthcare providers.
  • The antibiotics market is growing owing to the increasing consumption of antibiotics in middle and lower-income countries, huge investments in R&D activities by pharmaceutical companies, and the increasing number of infectious diseases.
  • Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market.

Sepsis Alliance Launches POWER the AMRevolution, a National Initiative to Educate About the Risks of Antimicrobial Resistance and Steps to End Superbugs

Retrieved on: 
Monday, March 29, 2021
Articles, Health sciences, Pharmaceuticals policy, Sepsis, Sepsis Alliance, Health, Antimicrobial resistance, Antimicrobial

As part of the POWER the AMRevolution initiative, Sepsis Alliance fielded a global survey to assess understanding of antimicrobial resistance around the world.

Key Points: 
  • As part of the POWER the AMRevolution initiative, Sepsis Alliance fielded a global survey to assess understanding of antimicrobial resistance around the world.
  • According to the survey results, nearly 50 percent of adults are unaware of the term "antimicrobial resistance."
  • Sepsis is one of the biggest health risks related to antimicrobial resistance.
  • To learn more about the dangers of antimicrobial resistance, sepsis, and the steps that can help end superbugs, visit http://www.endsuperbugs.org .

Novo Holdings REPAIR Impact Fund Announces Second Global Call for New Investment Proposals to Fight AMR

Retrieved on: 
Monday, March 29, 2021
Articles, Antimicrobial resistance, Evolutionary biology, Pharmaceuticals policy, Veterinary medicine, Life sciences

COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).

Key Points: 
  • COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).
  • This is the EUR135 (USD 165) million REPAIR Impact Fund's sixth call for investment proposals since it was set up in 2018, and second global call.
  • To date, REPAIR has received over 200 investment proposals and has made nine investments in its commitment to help tackle the global AMR crisis.
  • Aleks Engel, Partner at Novo Holdings and Director of the REPAIR Impact Fund, said: "AMR is very much the 'other' raging pandemic in addition to the all-pervasive COVID-19 crisis.

Novo Holdings REPAIR Impact Fund Announces Second Global Call for New Investment Proposals to Fight AMR

Retrieved on: 
Monday, March 29, 2021
Articles, Antimicrobial resistance, Evolutionary biology, Pharmaceuticals policy, Veterinary medicine, Life sciences

COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).

Key Points: 
  • COPENHAGEN, Denmark, March 29, 2021 /PRNewswire/ -- Today, the Novo Holdings REPAIR Impact Fund announced the opening of its next investment proposal round for international life science companies developing new treatments to combat antimicrobial resistance (AMR).
  • This is the EUR135 (USD 165) million REPAIR Impact Fund's sixth call for investment proposals since it was set up in 2018, and second global call.
  • To date, REPAIR has received over 200 investment proposals and has made nine investments in its commitment to help tackle the global AMR crisis.
  • Aleks Engel, Partner at Novo Holdings and Director of the REPAIR Impact Fund, said: "AMR is very much the 'other' raging pandemic in addition to the all-pervasive COVID-19 crisis.

Global Antibiotics Market (2020 to 2026) - by Action Mechanism, Drug Class and Region - ResearchAndMarkets.com

Retrieved on: 
Friday, March 26, 2021
Health, Pharmaceutical, Health sciences, Health, Articles, Beta-lactam antibiotics, Evolutionary biology, Pharmaceuticals policy, Veterinary medicine, Beta-lactamase inhibitors, Antimicrobial resistance, β-Lactamase inhibitor, Antibiotic, Beta-lactamase

The "Global Antibiotics Market By Action Mechanism, By Drug Class, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Antibiotics Market By Action Mechanism, By Drug Class, By Region, Industry Analysis and Forecast, 2020 - 2026" report has been added to ResearchAndMarkets.com's offering.
  • The Global Antibiotics Market size is expected to reach $62.5 billion by 2026, rising at a market growth of 5.3% CAGR during the forecast period.
  • Presently, the demand for beta-lactam and beta-lactamase inhibitors class of antibiotics is more among healthcare providers.
  • Although, the development of antibiotic resistance and the rising cost of drug approval hinder the growth of the antibiotic market.

Viva! inspires MPs to urge UK Government to 'ban factory farming'

Retrieved on: 
Thursday, March 25, 2021
Articles, Animal welfare, Ethics, Animal rights, Cruelty to animals, Meat industry, Livestock, Intensive animal farming, Antimicrobial resistance

Factory farming is responsible for mass animal suffering, the rise of antimicrobial resistance, and the spread of potentially lethal diseases, the MPs warned.

Key Points: 
  • Factory farming is responsible for mass animal suffering, the rise of antimicrobial resistance, and the spread of potentially lethal diseases, the MPs warned.
  • In the UK, there are 1,674 operational factory farms, with almost 800 of those classed as megafarms.
  • As a result some one billion animals in the UK are exposed to factory farming methods each year.
  • "We strongly urge the Government to listen to Parliament and the will of the people, and outlaw the abhorrent practice of factory farming in the UK for good."

Preparing for the Next Pandemic Requires New, Effective Antibiotic Treatments to Fight Infection

Retrieved on: 
Wednesday, March 17, 2021
Communications, Health, Infectious diseases, Social media, General Health, Pharmaceutical, Articles, Health, Global issues, Epidemiology, Pandemics, Public Health Emergency of International Concern, Antimicrobial resistance, Infection, Antimicrobial, COVID-19 pandemic

As we mark one-year of the global COVID-19 pandemic, the widespread impact of infectious disease has become all too clear.

Key Points: 
  • As we mark one-year of the global COVID-19 pandemic, the widespread impact of infectious disease has become all too clear.
  • While discussions around infectious disease have advanced considering the current pandemic, critical steps are needed to prepare for future pandemics.
  • The Partnership to Fight Infectious Disease (PFID) is working to motivate action on ending one such threat: Antimicrobial Resistance (AMR).
  • For more information about the Partnership to Fight Infectious Disease, visit www.fightinfectiousdisease.org , on Twitter @ThePFID and LinkedIn .

Armata Pharmaceuticals to Present at the Oppenheimer 31st Annual Healthcare Conference

Retrieved on: 
Tuesday, March 16, 2021
Bacteria, Medical specialties, Microbiology, Pathogenic bacteria, Gram-negative bacteria, Pseudomonadales, Bacterial diseases, Antibiotic-resistant bacteria, Bacteriophage, Pseudomonas, Staphylococcus aureus, Antimicrobial resistance

MARINA DEL REY, Calif., March 16, 2021 /PRNewswire/ --Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will participate in the Oppenheimer 31st Annual Healthcare Conference taking place virtually March 16-18, 2021.

Key Points: 
  • MARINA DEL REY, Calif., March 16, 2021 /PRNewswire/ --Armata Pharmaceuticals, Inc. (NYSE American: ARMP) ("Armata" or the "Company"), a biotechnology company focused on pathogen-specific bacteriophage therapeutics for antibiotic-resistant and difficult-to-treat bacterial infections, today announced that the Company will participate in the Oppenheimer 31st Annual Healthcare Conference taking place virtually March 16-18, 2021.
  • Management is scheduled to present at 3:10pm ET on Wednesday, March 17.
  • Armata is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens.
  • Armata is committed to advancing phage with drug development expertise that spans bench to clinic including in-house phage specific GMP manufacturing.

Veterinary Antimicrobial Susceptibility Testing Market worth $135 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, March 12, 2021
Articles, Microbiology, Branches of biology, Biology, Etest, Antimicrobial resistance, Antimicrobial

The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.

Key Points: 
  • The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.
  • Based on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals.
  • Based on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users.
  • Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025

Veterinary Antimicrobial Susceptibility Testing Market worth $135 million by 2026 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Friday, March 12, 2021
Articles, Microbiology, Branches of biology, Biology, Etest, Antimicrobial resistance, Antimicrobial

The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.

Key Points: 
  • The rising focus on veterinary antimicrobial susceptibility testing in emerging markets due to supportive government initiatives and awareness initiatives for antimicrobial resistance and control offer significant growth opportunities for the market players.
  • Based on animal type, the veterinary antimicrobial susceptibility testing market is segmented into food-producing animals and companion animals.
  • Based on end users, the veterinary antimicrobial susceptibility testing market is segmented into veterinary reference laboratories, veterinary research institutes and universities, and other end users.
  • Antimicrobial Susceptibility Testing Market by Product (Manual, Automated Susceptibility Testing System), Type (Antibacterial, Antifungal), Application (Clinical Diagnostics), Method (ETEST, Disk Diffusion), End-User - Global Forecasts to 2025